Christine Jones

2.1k total citations · 1 hit paper
36 papers, 1.4k citations indexed

About

Christine Jones is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Christine Jones has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Christine Jones's work include Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Asthma and respiratory diseases (9 papers) and Inhalation and Respiratory Drug Delivery (8 papers). Christine Jones is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Asthma and respiratory diseases (9 papers) and Inhalation and Respiratory Drug Delivery (8 papers). Christine Jones collaborates with scholars based in United States, United Kingdom and Denmark. Christine Jones's co-authors include David A. Lipson, Sally Kilbride, Gerard J. Criner, Mark T. Dransfield, Fernando J. Martínez, Peter Lange, Robert A. Wise, Dave Singh, MeiLan K. Han and David Halpin and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Christine Jones

34 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

2018 758 citations David A. Lipson, Frank Barnhart et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine Jones United States	13	1.0k	681	102	95	72	36	1.4k
P Bakke Norway	14	747 0.7×	471 0.7×	86 0.8×	36 0.4×	69 1.0×	23	1.0k
Brigitte W.M. Willemse Netherlands	14	1.3k 1.3×	682 1.0×	151 1.5×	39 0.4×	182 2.5×	31	1.7k
Christopher Burgess United Kingdom	9	391 0.4×	503 0.7×	160 1.6×	63 0.7×	62 0.9×	30	939
Joseph C. Kidney United Kingdom	17	707 0.7×	470 0.7×	261 2.6×	48 0.5×	141 2.0×	32	1.1k
Désirée F. Jansen Netherlands	12	377 0.4×	275 0.4×	55 0.5×	31 0.3×	100 1.4×	14	907
Min‐Suk Yang South Korea	22	318 0.3×	634 0.9×	84 0.8×	50 0.5×	67 0.9×	93	1.5k
Debbie Benner United States	19	130 0.1×	495 0.7×	67 0.7×	97 1.0×	75 1.0×	27	1.4k
R. Escamilla France	18	779 0.8×	430 0.6×	222 2.2×	16 0.2×	69 1.0×	62	1.1k
Stanislav Šuškovič Slovenia	14	388 0.4×	340 0.5×	59 0.6×	36 0.4×	61 0.8×	25	863
Xinhua Yu United States	13	279 0.3×	420 0.6×	165 1.6×	40 0.4×	89 1.2×	14	1.1k

Countries citing papers authored by Christine Jones

Since Specialization

Citations

This map shows the geographic impact of Christine Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Jones more than expected).

Fields of papers citing papers by Christine Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Jones. The network helps show where Christine Jones may publish in the future.

Co-authorship network of co-authors of Christine Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Jones. A scholar is included among the top collaborators of Christine Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Jones. Christine Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, MeiLan K., Gerard J. Criner, Mark T. Dransfield, et al.. (2021). Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis. ERJ Open Research. 7(1). 663–2020. 7 indexed citations

Han, MeiLan K., Gerard J. Criner, Mark T. Dransfield, et al.. (2020). The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 202(9). 1237–1243. 20 indexed citations

Lipson, David A., Courtney Crim, Gerard J. Criner, et al.. (2020). Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 201(12). 1508–1516. 146 indexed citations

Halpin, David, Gerard J. Criner, Mark T. Dransfield, et al.. (2020). Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial. Pulmonary Therapy. 7(1). 101–118. 5 indexed citations

Day, Nicola C., Gerard J. Criner, Mark T. Dransfield, et al.. (2020). Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial. Respiratory Research. 21(1). 139–139. 10 indexed citations

Marı́n, José M., José Echave-Sustaeta, Sergi Pascual-Guàrdia, et al.. (2020). Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT. Therapeutic Advances in Respiratory Disease. 14. 3272698061–3272698061. 1 indexed citations

Tabberer, Maggie, Christine Jones, Sally Kilbride, et al.. (2020). Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study. Advances in Therapy. 37(9). 3775–3790. 10 indexed citations

Dransfield, Mark T., Courtney Crim, Gerard J. Criner, et al.. (2020). Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT. Annals of the American Thoracic Society. 18(5). 788–798. 16 indexed citations

Lipson, David A., Gerard J. Criner, Mark T. Dransfield, et al.. (2019). The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies: Efficacy across multiple COPD endpoints over time. Research at the University of Copenhagen (University of Copenhagen). PA2482–PA2482. 1 indexed citations

10.

Kato, Motokazu, Keisuke Tomii, Kenichi Hashimoto, et al.. (2019). The IMPACT Study – Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population. International Journal of COPD. Volume 14. 2849–2861. 21 indexed citations

11.

Blum, Werner, Jürgen Klammt, Serge Amselem, et al.. (2018). Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes. EBioMedicine. 36. 390–400. 22 indexed citations

12.

Lipson, David A., Frank Barnhart, Noushin Brealey, et al.. (2018). Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. New England Journal of Medicine. 378(18). 1671–1680. 758 indexed citations breakdown →

13.

Hoyer‐Kuhn, Heike, Jeremy Franklin, Christine Jones, Werner Blum, & Eckhard Schöenau. (2017). Growth response to growth hormone treatment in patients with SHOX deficiency can be predicted by the Cologne prediction model. Journal of Pediatric Endocrinology and Metabolism. 31(1). 25–31. 4 indexed citations

14.

Child, Christopher J., G. Kalifa, Christine Jones, et al.. (2015). Radiological Features in Patients with Short Stature Homeobox-Containing (SHOX) Gene Deficiency and Turner Syndrome before and after 2 Years of GH Treatment. Hormone Research in Paediatrics. 84(1). 14–25. 17 indexed citations

15.

Blum, Werner, Dachuang Cao, V. Hesse, et al.. (2009). Height Gains in Response to Growth Hormone Treatment to Final Height Are Similar in Patients with SHOX Deficiency and Turner Syndrome. Hormone Research in Paediatrics. 71(3). 167–172. 47 indexed citations

16.

Jones, Christine, et al.. (2007). Managing Chronic Obstructive Pulmonary Disease. Wiley eBooks. 2 indexed citations

17.

Hauck, Yvonne, Wendy A. Hall, & Christine Jones. (2007). Prevalence, self‐efficacy and perceptions of conflicting advice and self‐management: effects of a breastfeeding journal. Journal of Advanced Nursing. 57(3). 306–317. 42 indexed citations

18.

Jones, Christine. (2002). Indiana University: The Transition to Coeducation. Indiana Magazine of History (Indiana University).

19.

Jones, Christine. (1996). Pastoral value and production from native pastures. New Zealand Journal of Agricultural Research. 39(4). 449–456. 18 indexed citations

20.

Garden, D. L., et al.. (1996). Regional research on native grasses and native grass‐based pastures. New Zealand Journal of Agricultural Research. 39(4). 471–485. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact